https://www.selleckchem.com/pr....oducts/pkm2-inhibito
0001). Among patients aged 50years, 95.1% had RS concordance between tumors (same subtype, 98.2%; variable subtype, 88.9%; p = 0.1). Among patients aged ≤ 50years, RS concordance was 81.6%. Among patients with MF/MC BC, RS concordance was high, particularly in those aged 50years with tumors of the same histologic subtype. RS testing of one focus may be sufficiently prognostic and predictive in patients aged 50years, regardless of subtype concordance. Testing of individual foci should be considered in pa
Like
Comment
Share
